|
Z-endoxifen Clinical Trials
3 actively recruiting trials across 3 locations
Also known as: endoxifen
Birmingham, Alabama1 trial
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
University of Alabama at Birmingham
Phase 2
Phoenix, Arizona1 trial
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Mayo Clinic Arizona
Phase 2
Berkeley, California1 trial
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
Berkeley Outpatient Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.